Details for New Drug Application (NDA): 080377
✉ Email this page to a colleague
NDA 080377 describes LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE, which is a drug marketed by Abbott, Bel Mar, Dell Labs, Intl Medication, and Watson Labs, and is included in eight NDAs. Additional details are available on the LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
The generic ingredient in LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE is epinephrine; lidocaine hydrochloride. There are twenty-one drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 080377
| Tradename: | LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE |
| Applicant: | Watson Labs |
| Ingredient: | epinephrine; lidocaine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.01MG/ML;1% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
